Effects of Different Dialysis Strategies on Inflammatory Cytokine Profile in Maintenance Hemodialysis Patients with

Pasquale Esposito1,2, Leda Cipriani1, Daniela Verzola1

  • 1Department of Internal Medicine, University of Genova, 16132 Genova, Italy.

Insights

In hemodialysis patients with COVID-19, inflammation is not sustained. Expanded hemodialysis (HDx) showed a decrease in interleukin-10 (IL-10) levels, unlike standard treatment. Therapeutic modulation of inflammation is not a viable target in this patient group.

Area of Science:

  • Nephrology
  • Immunology
  • Infectious Diseases

Background:

  • Uncontrolled inflammation is implicated in COVID-19 pathogenesis.
  • Hemodialysis (HD) patients represent a vulnerable population for severe COVID-19 outcomes.
  • Understanding inflammatory marker dynamics in HD patients with COVID-19 is crucial.

Purpose of the Study:

  • To investigate the time trend of inflammatory markers in maintenance HD patients with COVID-19.
  • To compare the effects of expanded hemodialysis (HDx) versus standard protein-leaking dialyzer (PLD) treatment on inflammatory markers.
  • To determine if modulating inflammation is a suitable therapeutic target in this population.

Main Methods:

  • Prospective study involving 31 maintenance HD patients with COVID-19.
  • Randomization to either HDx (medium cut-off membrane) or PLD treatment.
  • Measurement of circulating levels of IL-6, IL-8, IL-10, sTLR4, and IFN-γ at diagnosis, and at one and two weeks post-diagnosis.

Main Results:

  • COVID-19 patients exhibited lymphopenia and elevated ferritin and lactate dehydrogenase compared to non-infected HD patients.
  • COVID-19 patients presented higher baseline IL-10 levels.
  • While IL-8 decreased in both HDx and PLD groups, IL-10 reduction was observed only in the HDx group after a single treatment. No significant sustained differences in cytokine levels were found between HDx and PLD groups over the study period. No correlations between cytokine levels and clinical outcomes were identified.

Conclusions:

  • COVID-19 in maintenance HD patients is not characterized by a sustained inflammatory response.
  • The observed inflammatory profile suggests that therapeutic modulation of inflammation may not be an effective strategy for COVID-19 in this specific patient cohort.
  • Expanded hemodialysis (HDx) may influence specific cytokine dynamics, but overall inflammatory modulation is not a primary therapeutic target.

Related Concept Videos

Hemodialysis III: Nursing Management01:25

Hemodialysis III: Nursing Management

The nursing management of a patient undergoing hemodialysis includes several critical steps, starting with a thorough assessment before the procedure.Before the Hemodialysis ProcedureFirst, record the patient's vital signs—blood pressure, heart rate, respiratory rate, and temperature—to establish a baseline. This baseline is essential for detecting conditions such as hypotension that could impact the patient's response to dialysis. Document the patient's pre-dialysis weight, as this...
383
Acute Kidney Injury V: Interprofessional Care01:20

Acute Kidney Injury V: Interprofessional Care

Acute Kidney Injury (AKI) requires a collaborative healthcare approach to restore renal function and prevent complications. Essential management strategies involve monitoring fluid and electrolyte balance, adjusting medications, initiating dialysis when necessary, and providing nutritional support.Fluid and Electrolyte ManagementFluid Monitoring: Regularly monitoring body weight, central venous pressure, and urine output helps detect fluid imbalances early. Patient intake and output are...
112
Dialysis01:27

Dialysis

Renal failure occurs when the kidneys lose their ability to filter waste products from the blood effectively. It can be classified into two types: acute renal failure (ARF) and chronic renal failure (CRF).
Acute kidney injury develops suddenly and can be caused by pre-renal causes (e.g., hypovolemia, shock), intrinsic renal causes (e.g., acute tubular necrosis), or post-renal causes (e.g., urinary obstruction). In contrast, chronic renal failure progresses gradually over time and is often...
843
Dialysis01:15

Dialysis

Dialysis is a diffusion-based purification process that separates analyte molecules from a complex matrix. This is accomplished by allowing molecules in the solution to pass through a semipermeable membrane into a liquid on the other side. The membrane is usually made of cellulose acetate or cellulose nitrate, and the second liquid must be miscible with the solution. Ions (e.g., chloride or sodium) or organic molecules (e.g., glucose) can pass through the membrane pores, which generally have...
1.1K
Hemodialysis II: Procedure and Complications01:24

Hemodialysis II: Procedure and Complications

DialyzersA hemodialysis (HD) dialyzer is a plastic cartridge containing thousands of parallel hollow fibers, which serve as semipermeable membranes. These fibers are typically made from cellulose-based or other synthetic materials. During HD, blood is pumped into the top of the cartridge and distributed among these fibers. Simultaneously, dialysis fluid, known as dialysate, is introduced into the bottom of the cartridge, bathing the outside of the fibers. Across the semipermeable membrane,...
266
Chronic Kidney Disease III: Interprofessional Care01:28

Chronic Kidney Disease III: Interprofessional Care

Chronic kidney disease (CKD) requires collaborative and comprehensive management. CKD progresses through stages and can lead to end-stage kidney disease (ESKD) if untreated. Interprofessional collaboration and patient education are crucial, enabling patients to manage their health and improve their quality of life.Diagnostic approach for chronic kidney diseaseThe diagnosis of CKD primarily focuses on the glomerular filtration rate (GFR), which assesses kidney function by measuring how well...
179